⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL213695 | 0.70 | — | — | |
| SCHEMBL646321 | 0.67 | — | — | |
| SCHEMBL1500470 | 0.67 | — | — | |
| SCHEMBL12005226 | 0.67 | — | — | |
| SCHEMBL29125637 | 0.67 | — | — | |
| SCHEMBL29084440 | 0.67 | — | — | |
| SCHEMBL29099030 | 0.64 | — | — | |
| SCHEMBL7702462 | 0.64 | — | — | |
| SCHEMBL442336 | 0.64 | — | — | |
| SCHEMBL153732 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-217147140-U | Phosphoramidite phosphorus reagent storage box | 天津全和诚科技有限责任公司 | 2022-08-09 | — | — | CN | claimed |
| JP-10251281-A | — | — | None | — | — | JP | disclosed |
| JP-10251281-A | — | — | None | — | — | JP | disclosed |
| CN-116942841-A | Targeting ligands | 箭头药业股份有限公司 | 2023-10-27 | — | — | CN | disclosed |
| CN-116832169-A | Targeting ligands | 箭头药业股份有限公司 | 2023-10-03 | — | — | CN | disclosed |
| CN-109462981-B | Targeting ligands | 箭头药业股份有限公司 | 2023-07-07 | — | — | CN | disclosed |
| CN-217147140-U | Phosphoramidite phosphorus reagent storage box | 天津全和诚科技有限责任公司 | 2022-08-09 | — | — | CN | disclosed |
| CN-104725170-B | Hydroformylation process | 陶氏技术投资有限责任公司 | 2019-08-23 | — | — | CN | disclosed |
| CN-109983128-A | Oligonucleotide composition and its method | 波涛生命科学有限公司 | 2019-07-05 | — | — | CN | disclosed |
| EP-3500581-A1 | POLYNUCLEOTIDE CONSTRUCTS | Solstice Biologics, Ltd. (IE) | 2019-06-26 | — | — | EP | disclosed |
| CN-104379258-A | Hydroformylation process | DOW TECHNOLOGY INVESTMENTS LLC | 2015-02-25 | — | — | CN | disclosed |
| CN-103702758-A | Method for storing transition metal organophosphorus ligand-based catalyst | DOW TECHNOLOGY INVESTMENTS LLC | 2014-04-02 | — | — | CN | disclosed |
| CN-103402961-A | Mitigating fouling in hydroformylation processes by adding water | DOW TECHNOLOGY INVESTMENTS LLC | 2013-11-20 | — | — | CN | disclosed |
| US-6310198-B1 | NUCLEOTIDE PHOSPHOROTHIOATES WITH LITTLE OR NO PHOSPHATE ESTER FOR USE AS ANTISENSE AGENTS; SULFURIZATION OF PROTECTED DINUCLEOTIDES | AVECIA BIOTECHNOLOGY INC. | 2001-10-30 | — | — | US | disclosed |
| US-6087491-A | EFFICIENT PROCESS BY SYNTHESIZING OLIGONUCLEOTIDE WITH DIMER BLOCKS USING PHOSPHORAMIDITE CHEMISTRY AND SUBJECTING THE FULL-LENGTH, OLIGONUCLEOTIDE TO CHROMATOGRAPHY PURIFICATION; REDUCTION IN SOLVENT USE AND BY-PRODUCT PRODUCTION | HYBRIDON, INC. (US) | 2000-07-11 | — | — | US | disclosed |
| JP-H10251281-A | PHOSPHOROUS ACID AMIDE PHOSPHINE | F HOFFMANN LA ROCHE AG | 1998-09-22 | — | — | JP | disclosed |
| JP-H10251281-A | PHOSPHOROUS ACID AMIDE PHOSPHINE | F HOFFMANN LA ROCHE AG | 1998-09-22 | — | — | JP | disclosed |
| US-5721355-A | Method of attaching a fluorescent label to an oligonucleotide | PHARMACIA BIOTECH INC. (US) | 1998-02-24 | — | — | US | disclosed |
| US-5583236-A | PRIMERS FOR DNA SEQUENCING | PHARMACIA BIOTECH INC. (US) | 1996-12-10 | — | — | US | disclosed |
| US-5371241-A | Fluorescein labelled phosphoramidites | PHARMACIA P-L BIOCHEMICALS INC. (US) | 1994-12-06 | — | — | US | disclosed |